Literature DB >> 2024459

Limited sequence variation in human T-lymphotropic virus type 1 isolates from North American and African patients.

E Paine1, J Garcia, T C Philpott, G Shaw, L Ratner.   

Abstract

Nucleotide sequences were determined from the env genes of three HTLV-I clones derived from two North American patients and one African patient with adult T-cell leukemia/lymphoma (ATLL). In addition, sequences from the pX region, between env and the 3'LTR, were determined from one of these isolates. These data were compared to sequences derived from HTLV-I isolates of two Japanese ATLL patients, a Japanese patient with HTLV-I-associated myelopathy or tropical spastic paraparesis (HAM/TSP) and a Caribbean ATLL patient. Nucleotide sequence variation was found to be less than 6% in coding and noncoding regions. Predicted amino acid sequences varied between 0.6 and 1.8% in the envelope, 0-3.7% in rex, 0.8-2.5% in the tax gene product, and 3-14.0% in the pX-I open reading frame. Comparisons of the predicted amino acid sequences of the surface envelope protein (SU-gp46) suggest that the variation between isolates of different geographical origins is greater than that between isolates obtained from the same region of the world.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2024459     DOI: 10.1016/0042-6822(91)90654-t

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  30 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

Review 2.  The origin and evolution of human T-cell lymphotropic virus types I and II.

Authors:  Y Suzuki; T Gojobori
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

3.  Complete nucleotide sequence of the new simian T-lymphotropic virus, STLV-PH969 from a Hamadryas baboon, and unusual features of its long terminal repeat.

Authors:  M Van Brüssel; P Goubau; R Rousseau; J Desmyter; A M Vandamme
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Human T-lymphotropic virus type 1 in coastal natives of British Columbia: phylogenetic affinities and possible origins.

Authors:  F J Picard; M B Coulthart; J Oger; E E King; S Kim; J Arp; G P Rice; G A Dekaban
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

5.  Isolation and characterization of a new simian T-cell leukemia virus type 1 from naturally infected celebes macaques (Macaca tonkeana): complete nucleotide sequence and phylogenetic relationship with the Australo-Melanesian human T-cell leukemia virus type 1.

Authors:  F Ibrahim; G de Thé; A Gessain
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein.

Authors:  L Delamarre; C Pique; D Pham; T Tursz; M C Dokhélar
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

7.  Evolutionary insights on the origin of human T-cell lymphoma/leukemia virus type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea.

Authors:  M P Sherman; N K Saksena; D K Dube; R Yanagihara; B J Poiesz
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

8.  Evolution in a chronic RNA virus infection: selection on HTLV-I tax protein differs between healthy carriers and patients with tropical spastic paraparesis.

Authors:  S Niewiesk; C R Bangham
Journal:  J Mol Evol       Date:  1996-04       Impact factor: 2.395

9.  Phenotypic and genotypic comparisons of human T-cell leukemia virus type 1 reverse transcriptases from infected T-cell lines and patient samples.

Authors:  Michael S Mitchell; Ellen T Bodine; Shawn Hill; Gerald Princler; Patricia Lloyd; Hiroaki Mitsuya; Masao Matsuoka; David Derse
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

10.  Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands.

Authors:  A Gessian; R Yanagihara; G Franchini; R M Garruto; C L Jenkins; A B Ajdukiewicz; R C Gallo; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.